Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Home Letters Funds Account

The Gabelli ABC Fund's investment thesis on SpringWorks Therapeutics, Inc. ($SWTXX) — Q2 2025 | Buyside Digest

All Pitches

View Letter Analysis

$SWTXXNASDAQSpringWorks Therapeutics, Inc.

BULL

The Gabelli ABC Fund—SWTXX

Fund Letter

Q2 2025

Published June 30, 2025

View Fund Profile

$1.00USD

+0.0% vs last month

$1.00Pitched

+0.0% since pitch

Market CapN/A

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

Technical Chart

From the Fund Letter

The Gabelli Funds Q2 2025 shareholder commentary details a volatile second quarter marked by a 21% temporary drawdown in equities, sharp spikes in oil prices, and Treasury yield swings driven by trade policy (tariffs). Despite this, the...

— Mario J. Gabelli, CFA, Willis Brucker

BSD Research Exclusive

Unlock Full Institutional Investment Theses

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

SUBSCRIBE TO BSD RESEARCH ($55/MO)Compare All Plans

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

What other investors think about $SWTXX, and what else The Gabelli ABC Fund is buying.

Other pitches on $SWTXX

Other investors who've written on SpringWorks Therapeutics, Inc.

No other institutional pitches found for this ticker yet.

View all $SWTXX pitches →